F083 Dietary fasting behaviors in Huntington’s disease patient population

<h3>Background</h3> Huntington’s disease (HD) is a neurodegenerative disorder that affects adults in the prime of life. Effective disease-modifying treatments remain elusive; however, recent studies suggest dietary fasting may benefit neurodegenerative diseases, including HD [1]. Although fasting has shown potential in animal studies and non-HD populations, it has yet to be explored in persons with HD. <h3>Aims</h3> Use a survey to gain insight into the prevalence of fasting habits in the HD community. The information will lay the foundation for future observational and interventional studies. <h3>Methods</h3> We developed a survey to collect information on individual HD diagnosis, Enroll-HD status, caloric consumption timing, dietary habits, and fasting practices. The survey was distributed by the HDSA. Responses were tracked and analyzed using descriptive statistical methods. <h3>Results</h3> Of the 116 respondents, 113 are at risk for HD or known to carry the HD gene, and 66 are active participants in Enroll-HD. Over 42% of respondents are currently or have previously practiced a dietary fasting protocol. Roughly 30% of these individuals have practiced intermittent fasting for over a year figure 1. <h3>Conclusions</h3> Various forms of dietary fasting are commonly practiced by persons in the HD community, including those participating in Enroll-HD. These results support the use of a secondary survey that will be released by our group in the coming months. The goal of this next study is to retrospectively assess the effects of dietary fasting habits by partnering with Enroll-HD to analyze clinical outcomes, markers of disease progression, and safety measures, such as weight change over time. <h3>References</h3> Wells RG, Neilson LE, McHill AW, Hiller AL. Dietary fasting and time-restricted eating in Huntington’s disease: therapeutic potential and underlying mechanisms. <i>Transl Neurodegener</i>. 2024;<b>13</b>(1):17 doi: 10.1186/s40035-024-00406-z.

Authors

Institutions

Publication Details

Published
2024-09-01
DOI
https://doi.org/10.1136/jnnp-2024-ehdn.201
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

F083 Dietary fasting behaviors in Huntington’s disease patient population

Russell G. Wells, Amie Hiller
Genetic Neurodegenerative Diseases
article

F083 Dietary fasting behaviors in Huntington’s disease patient population

Russell G. Wells, Amie Hiller
article en

Abstract

<h3>Background</h3> Huntington’s disease (HD) is a neurodegenerative disorder that affects adults in the prime of life. Effective disease-modifying treatments remain elusive; however, recent studies suggest dietary fasting may benefit neurodegenerative diseases, including HD [1]. Although fasting has shown potential in animal studies and non-HD populations, it has yet to be explored in persons with HD. <h3>Aims</h3> Use a survey to gain insight into the prevalence of fasting habits in the HD community. The information will lay the foundation for future observational and interventional studies. <h3>Methods</h3> We developed a survey to collect information on individual HD diagnosis, Enroll-HD status, caloric consumption timing, dietary habits, and fasting practices. The survey was distributed by the HDSA. Responses were tracked and analyzed using descriptive statistical methods. <h3>Results</h3> Of the 116 respondents, 113 are at risk for HD or known to carry the HD gene, and 66 are active participants in Enroll-HD. Over 42% of respondents are currently or have previously practiced a dietary fasting protocol. Roughly 30% of these individuals have practiced intermittent fasting for over a year figure 1. <h3>Conclusions</h3> Various forms of dietary fasting are commonly practiced by persons in the HD community, including those participating in Enroll-HD. These results support the use of a secondary survey that will be released by our group in the coming months. The goal of this next study is to retrospectively assess the effects of dietary fasting habits by partnering with Enroll-HD to analyze clinical outcomes, markers of disease progression, and safety measures, such as weight change over time. <h3>References</h3> Wells RG, Neilson LE, McHill AW, Hiller AL. Dietary fasting and time-restricted eating in Huntington’s disease: therapeutic potential and underlying mechanisms. <i>Transl Neurodegener</i>. 2024;<b>13</b>(1):17 doi: 10.1186/s40035-024-00406-z.

Oregon Health & Science University (US), VA Portland Health Care System (US)
Zero hunger
Openalex Percentile: Top 84%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

F083 Dietary fasting behaviors in Huntington’s disease patient population — Russell G. Wells, Amie Hiller · (2024) | TGRS Research Map | TGRS